TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novo Nordisk Fonden
Closing information (x1000 EUR)
Closing information | 2015/12 (consolidated) | 2014/12 (consolidated) | 2013/12 (consolidated) |
Turnover |
16,864,598
|
13,797,397
|
12,909,798 |
Earnings before taxes |
6,745,464
|
5,996,830
|
5,255,730 |
Total assets |
22,837,099
|
19,881,130
|
17,071,840 |
Current assets |
8,623,864
|
8,324,804
|
7,273,824 |
Current liabilities |
6,574,603
|
5,814,160
|
4,160,434 |
Equity capital |
15,021,575
|
13,086,191
|
11,979,359 |
- share capital |
2,948
|
2,955
|
2,949 |
Employees (average) |
26
|
51,059
|
43,066 |
Financial ratios
Fiscal year | 2015/12 (consolidated) | 2014/12 (consolidated) | 2013/12 (consolidated) |
Solvency |
65.8%
![]() |
65.8%
|
70.2% |
Turnover per employee |
648,638
|
270
|
300 |
Profit as a percentage of turnover |
40.0%
|
43.5%
|
40.7% |
Return on assets (ROA) | |||
Current ratio |
131.2%
|
143.2%
|
174.8% |
Return on equity (ROE) |
44.9%
|
45.8%
|
43.9% |
Change turnover |
3,098,818
|
860,029
|
907,251 |
Change turnover % |
23%
|
7%
|
8% |
Chg. No. of employees |
-51,033
|
7,993
|
3,764 |
Chg. No. of employees % |
-100%
|
19%
|
10% |
Total value of public sale
Fiscal year | 2015/12 (consolidated) | 2014/12 (consolidated) | 2013/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.